1 / 13

Health Economics and Technology Assessment Research Centre hecon.uni-corvinus.hu

19th Alzheimer Europe Conference Brussels, 28-30th May 2009. Epidemiology and Disease Burden of Dementia in Hungary. Katalin Érsek 1 , Krisztián Kárpáti 1 , Tibor Kovács 2 , László Gulácsi 1 1 Corvinus University of Budapest, 3 Semmelweis University, Clinics of Neurology.

christianj
Download Presentation

Health Economics and Technology Assessment Research Centre hecon.uni-corvinus.hu

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 19th Alzheimer Europe Conference Brussels, 28-30th May 2009 Epidemiology and Disease Burden of Dementia in Hungary Katalin Érsek1, Krisztián Kárpáti1, Tibor Kovács2, László Gulácsi1 1 Corvinus University of Budapest, 3 Semmelweis University, Clinics of Neurology Health Economics and Technology Assessment Research Centre http://hecon.uni-corvinus.hu

  2. Content • Epidemiology of dementia in Hungary • International context • Cross-sectional study in 2008 Aim: to investigate epidemiology, health status, health care utilisation and costs of dementia in Hungary • Results Health Economics and Technology Assessment Research Centre http://hecon.uni-corvinus.hu

  3. Dementia in Hungary Based on the estimation of the demented in Hungary there is a noticeable difference between the domestic and the internationally published data • According to international data of Hungary the number of demented is about 100 thousand – UNDERESTIMATION? (Wimo, Winblad, Jönsson 2007) • According to previous Hungarian studies, the number of the demented vary between 530 and 917 thousand –OVERESTIMATION?(Ersek et al 2009) Health Economics and Technology Assessment Research Centre http://hecon.uni-corvinus.hu

  4. Cross-sectional study design Questionnaires used • The Hungarian modified version of the Resource Utilization in Dementia (RUD) questionnaire to evaluate the resources and costs by disease severities – with extra questions • MMSE score as an indicator of the cognitive status • The validated Hungarian version of the EQ-5D questionnaire to evaluate the patients’ and their caregivers’ quality of life. Health Economics and Technology Assessment Research Centre http://hecon.uni-corvinus.hu

  5. Methods • With an outlook for the international literature and the available Hungarian information estimating the epidemiology of dementia in Hungary by age-groups and disease severity then make the estimation for the total population. • Assigning the disease-related costs to the patients we estimated the burden of dementia in Hungary – with cost issues calculated by the cross-sectional survey in 2008.

  6. Cross-sectional study design II. Sample • From 4 GP practices from 4 different cities and 1 outpatients setting of the Neurology Department - 88 consecutive patients and care givers were included – with interviewers’ guidance Baseline data • Patients’ mean age was 78 years (SD: 8,5 years), 59% were female. The average disease duration was 3 years (SD: 2,9 years), average MMSE score was 16,7 (SD: 7,24), while EQ-5D was 0,401 (SD: 0,327). • The caregivers’ mean age was 60 years and 72,7% of them were female. Average EQ-5D is 0,78. 39,7% of caregivers had part or full time job and 60,2% of them lived together with the patient. Health Economics and Technology Assessment Research Centre http://hecon.uni-corvinus.hu

  7. Result: epidemiology and costs Epidemiology • Based on a previous GP-setting’s survey (2001) the estimated prevalence of dementia in 2008 is for the 50-59, 60-69, 70-79 and above 80 years age-groups are 7%, 29%, 39% and 55%, respectively. As for the MMSE categories we can estimate 32% of the demented patients in the MMSE category 0-19 and 68% of patients in MMSE 20-26 group in 2008. Cost estimation • In the 2008 survey the average direct cost per patient was 278 EUR (sd. 532), while the indirect cost per patient amounted to EUR 52 (sd. 187). The average direct cost for the 65-75, the 75-85 and the 85+ age-groups were the following: EUR160, EUR283 and EUR419 respectively. Health Economics and Technology Assessment Research Centre http://hecon.uni-corvinus.hu

  8. Results: Comparing QoL values (General population data: Szende A, Németh R. 2004)

  9. Results: Average EQ-5D scores by MMSE categories and age-groups(n=88)

  10. Distribution of cost-issues

  11. Results: costs by MMSE categories and age-groups (n=88) Age-groups (1 = below 65 yrs, 3 = 65-75 yrs, 4 = 75-85 yrs, 5 = ≥85yrs)

  12. Conclusions • The estimated total direct cost of dementia in 2008 could result 0.25% from the GDP, furthermore 0.05% as indirect cost • There is a huge difference between the domestic and the internationally published data – that effect the cost of illness and financing issues. • Our survey can inform policy-makers, but it is a strong need for an extensive research to establish an effective and sustainable ageing policy management and financing in Hungary

  13. Thank you for your attention! http://hecon.uni-corvinus.hu

More Related